Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-21, Stock:ABT, The news for the past five days is as follows:
2018-09-14: NEWS1: Abbott Labs Declares Quarterly Dividend.NEWS2: Abbott Ireland Financing DAC -- Moody's assigns Baa1 to Abbott Lab's proposed Euro notes offering.
2018-09-17: NEWS1: Cyber Attack Fears Grip MedTech: 3 Safe Stocks.NEWS2: Cyber Attack Fears Grip MedTech: 3 Safe Stocks.NEWS3: A Look at Boston Scientific’s Valuation Multiples in September.NEWS4: Boston Scientific Stock in the Week Ended September 14.
2018-09-18: NEWS1: Medical - Products Stock Outlook: Short-Term Pain Inevitable.NEWS2: A Look at Hologic Stock’s Recent Performance.NEWS3: ABT or PETQ: Which Is the Better Value Stock Right Now?.NEWS4: ABT or PETQ: Which Is the Better Value Stock Right Now?.NEWS5: Here's Why You Should Add Abbott (ABT) to Your Portfolio Now.NEWS6: Here's Why You Should Add Abbott (ABT) to Your Portfolio Now.NEWS7: ABT or PETQ: Which Is the Better Value Stock Right Now?.NEWS8: Here&apos;s Why You Should Add Abbott (ABT) to Your Portfolio Now.NEWS9: Non-diabetics are using diabetes technology to track their blood sugar and improve their health.NEWS10: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS11: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.NEWS12: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.
2018-09-19: NEWS1: Abbott Hosts Conference Call for Third-Quarter Earnings.NEWS2: Medical - Products Stock Outlook: Short-Term Pain Inevitable.NEWS3: Medical - Products Stock Outlook: Short-Term Pain Inevitable.
2018-09-20: NEWS1: Abbott Banks on New Approvals and Buyouts, Competition Rife.NEWS2: Abbott Banks on New Approvals and Buyouts, Competition Rife.NEWS3: Abbott Banks on New Approvals and Buyouts, Competition Rife.NEWS4: ABT Returns Almost Double the S&P 500’s Year-to-Date Gain.NEWS5: Abbott Laboratories Stock Trades at Its 52-Week High in September.NEWS6: Analysts Are Overwhelmingly Bullish on Abbott Laboratories.NEWS7: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS8: [$$] Beto O’Rourke electrifies voters as he takes on Ted Cruz in Texas.

Answer: Rise